Dynorphin / kappa-opioid receptor regulation of excitation-inhibition balance toggles afferent control of prefrontal cortical circuits in a pathway-specific manner | Molecular Psychiatry
Opioid receptors: drivers to addiction? | Nature Reviews Neuroscience
Behavioral and Physiological Effects of a Novel Kappa-Opioid Receptor-Based DREADD in Rats | Neuropsychopharmacology
Frontiers | Knock-In Mouse Models to Investigate the Functions of Opioid Receptors in vivo
Kappa-opioid receptor-dependent changes in dopamine and anxiety-like or approach-avoidance behavior occur differentially across the nucleus accumbens shell rostro-caudal axis - ScienceDirect
Clozapine N-Oxide Administration Produces Behavioral Effects in Long–Evans Rats: Implications for Designing DREADD Experiments | eNeuro
Receptor activated solely by a synthetic ligand - Wikipedia
Frontiers | Dynorphin/kappa opioid receptor system regulation on amygdaloid circuitry: Implications for neuropsychiatric disorders
Modulating Dopamine Signaling and Behavior with Chemogenetics: Concepts, Progress, and Challenges | Pharmacological Reviews
New Technologies for Elucidating Opioid Receptor Function: Trends in Pharmacological Sciences
Behavioral and Physiological Effects of a Novel Kappa-Opioid Receptor-Based DREADD in Rats | Neuropsychopharmacology
PDF) A New DREADD Facilitates the Multiplexed Chemogenetic Interrogation of Behavior
![PDF] Clozapine N-Oxide Administration Produces Behavioral Effects in Long–Evans Rats: Implications for Designing DREADD Experiments | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c7b09d4a79773b4f3d7b0fec2825409ca299dac6/5-Figure1-1.png "PDF] Clozapine N-Oxide Administration Produces Behavioral Effects in Long–Evans Rats: Implications for Designing DREADD Experiments | Semantic Scholar")
PDF] Clozapine N-Oxide Administration Produces Behavioral Effects in Long–Evans Rats: Implications for Designing DREADD Experiments | Semantic Scholar
Clozapine N-Oxide Administration Produces Behavioral Effects in Long–Evans Rats: Implications for Designing DREADD Experiments | eNeuro
Frontiers | Traumatic Stress-Induced Vulnerability to Addiction: Critical Role of the Dynorphin/Kappa Opioid Receptor System
An updated assessment of the translational promise of G-protein-biased kappa opioid receptor agonists to treat pain and other indications without debilitating adverse effects - ScienceDirect
Frontiers | The Role of the Kappa Opioid System in Comorbid Pain and Psychiatric Disorders: Function and Implications
Ligand and G-protein selectivity in the κ-opioid receptor | Nature
Frontiers | The Use of DREADDs to Deconstruct Behavior
A Cre Driver Line for Genetic Targeting of Kappa Opioid Receptor Expressing Cells | eNeuro
The DREADD agonist clozapine N-oxide (CNO) is reverse-metabolized to clozapine and produces clozapine-like interoceptive stimulus effects in rats and mice | Scientific Reports
Chemogenetics drives paradigm change in the investigation of behavioral circuits and neural mechanisms underlying drug action - ScienceDirect
An Overview of Chemogenetics
![PDF] DREADDs for Neuroscientists | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/cc7db00617d97220b2f596e27279d1b9ea9bcf59/6-Figure3-1.png "PDF] DREADDs for Neuroscientists | Semantic Scholar")
PDF] DREADDs for Neuroscientists | Semantic Scholar
Resolving Behavioral Output via Chemogenetic Designer Receptors Exclusively Activated by Designer Drugs | Journal of Neuroscience
![PDF] DREADDs for Neuroscientists | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/cc7db00617d97220b2f596e27279d1b9ea9bcf59/2-Table1-1.png "PDF] DREADDs for Neuroscientists | Semantic Scholar")
PDF] DREADDs for Neuroscientists | Semantic Scholar
Kappa-opioid receptor stimulation in the nucleus accumbens shell: Differential effects across the rostro-caudal axis on dopamine transmission and affective behavior | bioRxiv
A Cre Driver Line for Genetic Targeting of Kappa Opioid Receptor Expressing Cells | eNeuro
